Trexquant Investment LP Buys New Holdings in AdaptHealth Corp. $AHCO

Trexquant Investment LP bought a new stake in AdaptHealth Corp. (NASDAQ:AHCOFree Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 21,022 shares of the company’s stock, valued at approximately $228,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Reinhart Partners LLC. boosted its holdings in AdaptHealth by 15.5% in the first quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company’s stock valued at $78,441,000 after acquiring an additional 969,408 shares during the last quarter. Palisade Capital Management LP raised its position in AdaptHealth by 12.3% in the first quarter. Palisade Capital Management LP now owns 2,711,142 shares of the company’s stock valued at $29,389,000 after purchasing an additional 297,268 shares during the period. Charles Schwab Investment Management Inc. raised its position in AdaptHealth by 14.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,301,652 shares of the company’s stock valued at $14,110,000 after purchasing an additional 163,272 shares during the period. Northern Trust Corp raised its position in AdaptHealth by 11.1% in the fourth quarter. Northern Trust Corp now owns 1,172,265 shares of the company’s stock valued at $11,160,000 after purchasing an additional 116,981 shares during the period. Finally, New York State Common Retirement Fund raised its position in AdaptHealth by 10.3% in the first quarter. New York State Common Retirement Fund now owns 836,773 shares of the company’s stock valued at $9,071,000 after purchasing an additional 78,211 shares during the period. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised AdaptHealth from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat, AdaptHealth currently has an average rating of “Buy” and a consensus target price of $13.40.

Get Our Latest Report on AdaptHealth

Insider Buying and Selling

In related news, Director David Solomon Williams III sold 8,200 shares of AdaptHealth stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $9.73, for a total value of $79,786.00. Following the completion of the transaction, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.55% of the company’s stock.

AdaptHealth Trading Down 2.0%

Shares of AHCO opened at $9.23 on Wednesday. The company has a market capitalization of $1.25 billion, a P/E ratio of 17.09, a P/E/G ratio of 1.05 and a beta of 1.59. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.70. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. The stock has a 50-day moving average price of $9.32 and a 200 day moving average price of $9.27.

AdaptHealth Company Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Articles

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.